You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 11, November 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Neuromuscular diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

SARS, SIRS, and Neurological Disease

Arch Neurol. 2004;61:1647-1648.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

One of the most demanding but engaging aspects of neurological practice is involvement in all aspects of medicine, from primary care of patients with migraine to consultation in the intensive care unit. There are few disorders that spare the nervous system, and neurologists participate in a vast range of problems. The neurological complications of newly emerging infections are no exception and have required active involvement. In the mid 1980s, neurological complications eventually linked to HIV infection ranged from primary dementia to small fiber sensory axonopathy. More recently, the impact of West Nile virus on the central and peripheral nervous systems has been devastating.

Severe acute respiratory syndrome (SARS), a pulmonary infection that erupted worldwide 1 year ago and is now linked to a virulent strain of coronavirus,1-2 has not been considered to primarily target the nervous system. In this issue of Archives of Neurology, however, Tsai et al,3 from . . . [Full Text of this Article]

AUTHOR INFORMATION

Douglas W. Zochodne, MD, FRCPC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.